Nystatin Dosing for Oral Thrush
For a 29-year-old female with antibiotic-associated oral thrush, prescribe nystatin suspension (100,000 U/mL) at a dose of 4-6 mL swished in the mouth and swallowed four times daily for 7-14 days 1, 2.
Specific Administration Instructions
- Dose: 4-6 mL (400,000-600,000 units) per administration
- Frequency: Four times daily
- Duration: 7-14 days
- Technique: Swish the suspension throughout the mouth for as long as possible before swallowing
- Important: Shake the bottle well before each use 3
Clinical Context and Severity Assessment
The IDSA guidelines classify this as mild disease since it's uncomplicated antibiotic-associated thrush in an immunocompetent young adult 1, 2. Nystatin suspension is specifically recommended as an alternative first-line agent for mild oropharyngeal candidiasis with strong recommendation and moderate-quality evidence.
Alternative Considerations
If the patient has difficulty with the taste or compliance issues (nystatin requires 4 daily doses and has poor palatability), consider:
- Clotrimazole troches 10 mg five times daily (also strong recommendation for mild disease) 1
- Fluconazole 100-200 mg daily for 7-14 days if disease appears moderate-to-severe (strong recommendation, high-quality evidence) 1
Research shows that approximately 50% of patients report inconvenience with nystatin due to taste and frequent dosing requirements 4, though it remains effective with clinical cure rates of 80-87% 4, 5.
Common Pitfalls to Avoid
- Inadequate contact time: Patients must swish the suspension thoroughly before swallowing—brief contact reduces efficacy
- Premature discontinuation: Complete the full 7-14 day course even if symptoms resolve earlier to prevent relapse
- Eating/drinking immediately after: Advise patients to avoid food or drink for 30 minutes after administration to maximize mucosal contact time
- Not shaking the bottle: The suspension settles and requires vigorous shaking before each dose 3
When to Escalate Therapy
If symptoms persist after 7-14 days of nystatin, this indicates fluconazole-refractory disease requiring escalation to:
- Itraconazole solution 200 mg once daily, OR
- Posaconazole suspension 400 mg twice daily for 3 days, then 400 mg daily 1
However, treatment failure with nystatin in an immunocompetent patient is uncommon and should prompt consideration of alternative diagnoses or non-adherence issues.